Skip to main content
Premium Trial:

Request an Annual Quote

Bernard Reculeau, Jeff Whitmore, Andre Marion

Cisbio this week announced that Bernard Reculeau has been appointed CEO.
Prior to joining Cisbio, Reculeau was managing director of Sanofi-Aventis International. He is a graduate of France’s National School of Administration and the Institute of Political Studies in Paris.

Alpha Innotech this week said that Jeff Whitmore has joined the company as vice president of global sales.
Whitmore most recently served as director of European life sciences sales for Molecular Devices in London. Prior to this, Whitmore held various sales positions for Molecular Devices and Bio-Rad Laboratories. He holds a BS in microbiology from the University of Wisconsin.

Singulex this week said that it has appointed Andre Marion to its board of directors.
Marion is the founder of Applied Biosystems, and served as its CEO from 1986 to 1993; and chairman of the board from 1987 to 1993, when it merged with Perkin-Elmer. Presently, Marion is a management consultant and director of several biotechnology companies, including Molecular Devices, Applied Imaging, Alpha MOS, and Guava Technologies.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.